WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis
Cancer Letters · 2024-11 · 604 · 217254
DOI: 10.1016/j.canlet.2024.217254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2024-11. Verfasst von Yue-Tao Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun …. Hauptthemen laut MEDLINE: Oxaliplatin, Colorectal Neoplasms, NF-E2-Related Factor 2, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: China Postdoctoral Science Foundation, Basic and Applied Basic Research Foundation of Guangdong Province, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
As the most abundant post-transcriptional modification in eukaryotes, N6-methyladenosine (m6A) plays a crucial role in cancer cell proliferation, invasion and chemoresistance. However, its specific effects on chemosensitivity to oxaliplatin-based regimens and the impact of these drugs on m6A methylation levels in colorectal cancer (CRC) remain largely unexplored. In this study, we demonstrated that the m6A methyltransferase Wilms tumor 1-associating protein (WTAP) weakens oxaliplatin chemosensitivity in HCT116 and DLD1 cells. Mechanistically, oxaliplatin treatment upregulated WTAP expression, preventing multiple forms of cell death simultaneously, a process known as PANoptosis, by decreasing intracellular oxidative stress through maintaining the expression of nuclear factor erythroid-2-related factor 2 (NRF2), a major antioxidant response element, in an m6A-dependent manner. In addition, high WTAP expression in CRC patients is associated with a poor prognosis and reduced benefit from standard chemotherapy by clinical data analysis of The Cancer Genome Atlas (TCGA) database and patient cohort study. These findings suggest that targeting WTAP-NRF2-PANoptosis axis could enhance the antitumor efficacy of oxaliplatin-based chemotherapy in CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, 510060, PR China.
- Department of Gastroenterology and Urology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, 410013, PR China.
- Department of Medical Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, 510632, PR China.
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, 510060, PR China; Department of Radiolo…
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, 510060, PR China; Department of Clinica…
- Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University, Guangzhou, 510060, PR China; Research Unit of Prec…
Förderung
- China Postdoctoral Science Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
- Natural Science Foundation of Hunan Province
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Tan, Y. T., Li, T., Wang, R. B., Liu, Z. K., Ma, M. Y., Huang, R. Z., Mo, H. Y., Luo, S. Y., Lin, J. F., Xu, R. H., & Ju, H. Q. (2024). WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis. Cancer Letters, 604, 217254. https://doi.org/10.1016/j.canlet.2024.217254
Vancouver
Tan YT, Li T, Wang RB, Liu ZK, Ma MY, Huang RZ, et al. WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis. Cancer Letters. 2024;604:217254. doi:10.1016/j.canlet.2024.217254
BibTeX
@article{Tan2024,
author = {Tan, Yue-Tao and Li, Ting and Wang, Ruo-Bing and Liu, Ze-Kun and Ma, Meng-Yao and Huang, Ren-Ze and Mo, Hai-Yu and Luo, Shu-Yu and Lin, Jin-Fei and Xu, Rui-Hua and Ju, Huai-Qiang},
title = {WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis},
journal = {Cancer Letters},
year = {2024},
volume = {604},
pages = {217254},
doi = {10.1016/j.canlet.2024.217254}
}
EUVIMED